The Industry

February 2010
Pharmaceutical Representative;Feb2010, Vol. 40 Issue 2, p7
The article offers world news briefs related to the pharmaceutical industry. Kinaxo Biotechnologies GmbH has partnered with Roche Diagnostics Corp. for the second time. The U.S. has filed a civil case against the drug manufacturer Johnson & Johnson and two of its subsidiaries Johnson & Johnson Health Care Systems Inc. and McNeil-Janssen Pharmaceuticals under the False Claims Act. Moreover, Gilead Sciences Inc. will close its Phase III trial for the hypertension treatment darusentan.


Related Articles

  • EVOTEC ACQUIRES KINAXO EXPANDING DRUG DISCOVERY PLATFORM.  // Worldwide Biotech;Mar2011, Vol. 23 Issue 3, p5 

    The article provides information on the takeover of drug company Kinaxo Biotechnologies GmbH by Evotech AG, Hamburg, Germany, to strengthen Evotech's leadership in pharmaceutical and biotechnology. It lists Kinaxo's capabilities which include cellular target profiling, kinaffinity and...

  • Rare Hiccups For J&J. Silverman, Ed // Contract Pharma;Mar/Apr2010, Vol. 12 Issue 2, p36 

    The article offers an overview of the production issues and kickback lawsuit faced by health care giant Johnson and Johson. The company's McNeil Consumer Healthcare unit was chastised by the U.S. Food and Drug Administration (FAD) for failing to follow up issues on its Tylenol Arthritis Relief...

  • Defendants Are Not Required to Provide Formula for Calculating Potential Damages. Duckels, Robert L.; Yager, Ryan J. // Business Torts Journal;Summer2013, Vol. 20 Issue 4, p26 

    The article discusses the court case Raskas v. Johnson & Johnson in Missouri state court. Three plaintiffs filed separate class action lawsuits against separate pharmaceutical companies alleging that the defendants violated the Missouri Merchandising Practices Act. It informs that the district...

  • Colorado Supreme Court Rules in Insolvency Case. Hyatt, Elizabeth J. // Business Torts Journal;Summer2013, Vol. 20 Issue 4, p27 

    The article offers information on the district court case involving Raskas v. Johnson & Johnson, presented in the Colorado Supreme Court. Three plaintiffs filed separate class action lawsuits in Missouri state court against separate pharmaceutical companies alleging that the defendants violated...

  • Collaborations Between Biotech And Pharmaceutical Companies: Oct. 1 - Nov. 24, 2009.  // BioWorld Insight;11/30/2009, Vol. 17 Issue 48, p6 

    The article presents the biotechnology and pharmaceutical companies collaborations between October 1, 2009 to November 24, 2009. AC Immune SA collaborated with Bayer Schering Pharma AG for diagnostic imaging of Alzheimer's disease. PepTcell Ltd. subsidiary Biocopea Ltd. partners with Sosei Group...

  • Enough Speculation, Time to Act. Henderson, Lisa // Applied Clinical Trials;Mar2011, Vol. 20 Issue 3, p10 

    An introduction to the journal is presented in which the editor discusses various reports published within the issue including one on the strategic alliance between pharmaceutical companies and clinical research organizations (CROs), the use of Palm Beach Research as a CRO for a Chinese...

  • RESEARCH & TECHNOLOGY.  // MondayMorning;10/18/2010, Vol. 18 Issue 38, p4 

    The article offers news briefs related to the pharmaceutical industry of the U.S. Mount Sinai School of Medicine, New York researchers discovered a gene associated with the onset of Type 2 diabetes also is found at lower-than-normal levels in people with Alzheimer's disease. Seattle Genetics...

  • Fallout from McNeil Recall Escalates. Wechsler, Jill // Pharmaceutical Executive;Jul2010, Vol. 30 Issue 7, p14 

    The article reports on the legal problems faced by Johnson & Johnson after the recall of children's medications of its subsidiary McNeil Consumer Healthcare in the U.S. It mentions that congressional committees of the Food & Drug Administration (FDA) have accused the company of delaying...

  • European Patent Granted for Chemical Proteomics Applications.  // International Labmate;2011, Vol. 36 Issue 5, p23 

    The article reports that the European Patent Office has granted Kinaxo Biotechnologies a patent on chemical proteomics applications.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics